TE_131
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | LTR33B, LTR33C |
|---|---|
| TE superfamily | ERV3 |
| TE class | LTR |
| Gene | TMEM51-AS1, - |
| Class | Chimeric, Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 2.61 |
| Counts of samples | TCGA_tumor:291; TCGA_normal:14; GTEx:111 |
| TSS | chr1(-):15171637 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_131.1 | TMEM51-AS1 | Chimeric | Non-coding | Non-coding | chr1(-):15117787,15117807,15118327,15118904,15120577,15120697,15120972,15121059,15124228,15124373,15152291,15171315,15171611,15171638 |
| teRNA_131.2 | TMEM51-AS1 | Chimeric | Non-coding | Non-coding | chr1(-):15117787,15117807,15118327,15118904,15120972,15121059,15124228,15124373,15152291,15171315,15171611,15171638 |
| teRNA_131.3 | TMEM51-AS1 | Chimeric | Non-coding | Non-coding | chr1(-):15117787,15117807,15124228,15124373,15152291,15171315,15171611,15171638 |
| teRNA_131.4 | TMEM51-AS1 | Chimeric | Non-coding | Non-coding | chr1(-):15121039,15121059,15124228,15124373,15152291,15171315,15171611,15171638 |
| teRNA_131.5 | TMEM51-AS1 | Chimeric | Non-coding | Non-coding | chr1(-):15124353,15124373,15152291,15171315,15171611,15171638 |
| teRNA_131.6 | - | Intergenic | Non-coding | Non-coding | chr1(-):15161457,15161477,15161902,15171315,15171611,15171638 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
